Suchergebnisse

16938 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: Frequenz, frequency, 頻度、周波数

• 2015, Yildirim ME, Kaynar M, Badem H, Cavis M, Karatas OF, Cimentepe E
  [Details] What is harmful for male fertility: Cell phone or the wireless internet? [epidem.]
  Kaohsiung J Med Sci 31 (9): 480-484
• 2015, Bakacak M, Bostanci MS, Attar R, Yildirim OK, Yildirim G, Bakacak Z, Sayar H, Han A
  [Details] The effects of electromagnetic fields on the number of ovarian primordial follicles: An experimental study [med./bio.]
  Kaohsiung J Med Sci 31 (6): 287-292
• 2023, Radiansyah RS, Hadi DW
  Repetitive transcranial magnetic stimulation in central post-stroke pain: current status and future perspective [Review]
  Korean J Pain 36 (4): 408-424
• 2019, Kim WJ, Park HS, Park MK
  The effect of needle tip position on the analgesic efficacy of pulsed radiofrequency treatment in patients with chronic lumbar radicular pain: a retrospective observational study [med. Anw.]
  Korean J Pain 32 (4): 280-285
• 2013, Park HL, Lim SM, Kim TH, Kang KH, Kang H, Jung YH, Baek CW, Woo YC, Kim JY, Koo GH, Shin HY
  Intractable hemifacial spasm treated by pulsed radiofrequency treatment [med. Anw.]
  Korean J Pain 26 (1): 62-64
• 2024, Choi S, Baek IS, Lee K, Kim SK
  Low-frequency auricular vagus nerve stimulation facilitates cerebrospinal fluid influx by promoting vasomotion [med./bio.]
  Korean J Physiol Pharmacol [im Druck]
• 2015, Jin H, Yoon HE, Lee JS, Kim JK, Myung SH, Lee YS
  [Details] Effects on G2/M phase cell cycle distribution and aneuploidy formation of exposure to a 60 Hz electromagnetic field in combination with ionizing radiation or hydrogen peroxide in L132 nontumorigenic human lung epithelial cells [med./bio.]
  Korean J Physiol Pharmacol 19 (2): 119-124
• 2015, Chung YH, Lee YJ, Lee HS, Chung SJ, Lim CH, Oh KW, Sohn UD, Park ES, Jeong JH
  [Details] Extremely low frequency magnetic field modulates the level of neurotransmitters [med./bio.]
  Korean J Physiol Pharmacol 19 (1): 15-20
• 2011, Hwang YH, Song HS, Kim HR, Ko MS, Jeong JM, Kim YH, Ryu JS, Sohn UD, Gimm YM, Myung SH, Sim SS
  [Details] Intracellular Ca Mobilization and Beta-hexosaminidase Release Are Not Influenced by 60 Hz-electromagnetic Fields (EMF) in RBL 2H3 Cells [med./bio.]
  Korean J Physiol Pharmacol 15 (5): 313-317
• 2011, Hong ME, Yoon KH, Jung YY, Lee TJ, Park ES, Sohn UD, Jeong JH
  [Details] Influence of exposure to extremely low frequency magnetic field on neuroendocrine cells and hormones in stomach of rats [med./bio.]
  Korean J Physiol Pharmacol 15 (3): 137-142
• 2010, Song HS, Kim HR, Ko MS, Jeong JM, Kim YH, Kim MC, Hwang YH, Sohn UD, Gimm YM, Myung SH, Sim SS
  [Details] Effect of Extremely Low Frequency Electromagnetic Fields (EMF) on Phospholipase Activity in the Cultured Cells [med./bio.]
  Korean J Physiol Pharmacol 14 (6): 427-433
• 2021, Knotkova H, Hamani C, Sivanesan E, Le Beuffe MFE, Moon JY, Cohen SP, Huntoon MA
  Neuromodulation for chronic pain [Review]
  Lancet 397 (10289): 2111-2124
• 2018, Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J
  Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial [med. Anw.]
  Lancet 391 (10131): 1683-1692
• 2001, Glikson M, Friedman PA
  [Details] The implantable cardioverter defibrillator [Review]
  Lancet 357 (9262): 1107-1117
• 1999, UK Childhood Cancer Study Investigators
  [Details] Exposure to power-frequency magnetic fields and the risk of childhood cancer [epidem.]
  Lancet 354 (9194): 1925-1931
• 1999, Tergau F, Naumann U, Paulus W, Steinhoff BJ
  Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy [Kommentar]
  Lancet 353 (9171): 2209
• 1998, Braune S, Wrocklage C, Raczek J, Gailus T, Lucking CH
  [Details] Resting blood pressure increase during exposure to a radio-frequency electromagnetic field [med./bio.]
  Lancet 351 (9119): 1857-1858
• 1998, Reid SW, Gettinby G
  Radio-frequency electromagnetic field from mobile phones [Kommentar]
  Lancet 352 (9127): 576-577
• 1990, Tynes T, Andersen A
  Electromagnetic fields and male breast cancer [Kommentar]
  Lancet 336 (8730): 1596
• 2008, Fregni F
  Towards novel treatments for paediatric stroke: is transcranial magnetic stimulation beneficial? [Kommentar]
  Lancet Neurol 7 (6): 472-473
• 2008, Kirton A, Chen R, Friefeld S, Gunraj C, Pontigon AM, Deveber G
  Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial [med. Anw.]
  Lancet Neurol 7 (6): 507-513
• 2023, Fennell DA
  Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer [Kommentar]
  Lancet Oncol 24 (9): 946-947
• 2023, Leal T, Kotecha R, Ramlau R, Zhang L, Milanowski J, Cobo M, Roubec J, Petruzelka L, Havel L, Kalmadi S, Ward J, Andric Z, Berghmans T, Gerber DE, Kloecker G, Panikkar R, Aerts J, Delmonte A, Pless M, Greil R, Rolfo C, Akerley W, Eaton M, Iqbal M, Langer C, LUNAR Study Investigators
  Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study [med. Anw.]
  Lancet Oncol 24 (9): 1002-1017
• 2019, Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, Mencoboni M, Planchard D, Chella A, Crinò L, Krzakowski M, Rüssel J, Maconi A, Gianoncelli L, Grosso F
  Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial [med. Anw.]
  Lancet Oncol 20 (12): 1702-1709
• 2011, Baan R, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Islami F, Galichet L, Straif K
  [Details] Carcinogenicity of radiofrequency electromagnetic fields [Review]
  Lancet Oncol 12 (7): 624-626